- Home
- OPOF vs CERS Comparison
OPOF vs CERS Comparison
Compare OPOF & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPOF
- CERS
- Stock Information
- Founded
- OPOF 1922
- CERS 1991
- Country
- OPOF United States
- CERS United States
- Employees
- OPOF N/A
- CERS N/A
- Industry
- OPOF Major Banks
- CERS EDP Services
- Sector
- OPOF Finance
- CERS Technology
- Exchange
- OPOF Nasdaq
- CERS Nasdaq
- Market Cap
- OPOF 212.5M
- CERS 255.0M
- IPO Year
- OPOF N/A
- CERS 1997
- Fundamental
- Price
- OPOF N/A
- CERS $1.33
- Analyst Decision
- OPOF
- CERS Strong Buy
- Analyst Count
- OPOF 0
- CERS 2
- Target Price
- OPOF N/A
- CERS $3.50
- AVG Volume (30 Days)
- OPOF 31.3K
- CERS 1.2M
- Earning Date
- OPOF 10-23-2025
- CERS 10-29-2025
- Dividend Yield
- OPOF 1.33%
- CERS N/A
- EPS Growth
- OPOF 21.17
- CERS N/A
- EPS
- OPOF 1.70
- CERS N/A
- Revenue
- OPOF $61,004,000.00
- CERS $192,510,000.00
- Revenue This Year
- OPOF N/A
- CERS $30.03
- Revenue Next Year
- OPOF N/A
- CERS $9.37
- P/E Ratio
- OPOF $24.72
- CERS N/A
- Revenue Growth
- OPOF 4.45
- CERS 13.25
- 52 Week Low
- OPOF $17.02
- CERS $1.12
- 52 Week High
- OPOF $42.68
- CERS $2.24
- Technical
- Relative Strength Index (RSI)
- OPOF 5.67
- CERS 54.10
- Support Level
- OPOF $40.71
- CERS $1.26
- Resistance Level
- OPOF $42.43
- CERS $1.34
- Average True Range (ATR)
- OPOF 0.56
- CERS 0.07
- MACD
- OPOF -2.62
- CERS 0.01
- Stochastic Oscillator
- OPOF 0.00
- CERS 62.07
About OPOF Old Point Financial Corporation
Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.